-
Recent, unexpected findings of nitrosamine impurities in drugs such as angiotensin II receptor blockers, ranitidine, nizatidine and metformin have raised RED FLAGS at the FDA.
Read More -
Exploring how inadequate U.S. FDA Type II Drug Master Files are one of the leading causes of delayed ANDA approvals.
Read More
